Navina secures $55M Series C led by Goldman Sachs to expand AI-driven healthcare intelligence
The Israeli startup aims to transform clinical workflows and improve patient outcomes.
Navina, a leading provider of AI-powered clinical intelligence, has raised $55 million in a Series C funding round, bringing its total funding to $100 million. The investment, led by Growth Equity at Goldman Sachs Alternatives with participation from existing investors Vertex Ventures Israel, Grove Ventures, and ALIVE, marks a significant step in the company’s expansion across the U.S. healthcare market.
The funding comes at a pivotal moment for healthcare, as the industry grapples with an increasingly complex data landscape, administrative inefficiencies, and a growing shift toward value-based care. Navina’s AI copilot is designed to address these challenges by surfacing real-time, data-driven insights that help clinicians deliver more proactive, efficient, and personalized patient care.
Navina was founded in 2018 by CEO Ronen Lavi and CTO Shay Perera, who were part of the team that set up the IDF’s Intelligence Corps AI lab.
Fragmented patient data and time-consuming administrative tasks often leave clinicians struggling to provide the most effective care. Navina’s platform integrates seamlessly into existing clinical workflows, synthesizing complex health records into concise, actionable insights. With over 10,000 healthcare professionals using the platform across 1,300 clinics, Navina has established itself as a significant player in the evolving healthcare landscape.
“AI is rapidly transforming modern healthcare, and Navina stands at the forefront of that transformation—delivering real, measurable value to thousands of clinicians,” said Irit Kahan, Managing Director in Growth Equity at Goldman Sachs Alternatives. “Their deep integration into clinical workflows, unparalleled provider trust, and demonstrated ROI make them uniquely positioned to drive meaningful impact across the healthcare ecosystem.”
Navina’s approach has already gained the trust of major healthcare organizations, including agilon health, InnovaCare Health, Millennium Physician Group, and Privia Health.
“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI,” said Ronen Lavi, Navina’s co-founder and CEO. “We’re thrilled to partner with a firm like Goldman Sachs as we enter this pivotal growth phase and expand our market reach.”
With the new capital, Navina plans to enhance its proprietary AI technology, further automate clinical workflows, and expand its capabilities from population health management to point-of-care interventions. The company aims to become the definitive source of unified patient data, enabling more efficient decision-making across healthcare ecosystems, from payers to providers.
